Validation of an in-house developed therapeutic dosimetric software tool for the treatment of 177Lutetium-DOTATATE peptide receptor radionuclide therapy
ConclusionOn average the relative percentage difference between the cumulated activities and absorbed dose of the two software were 10.7%.
Source: Health and Technology - Category: Information Technology Source Type: research
More News: African Health | Brain | CT Scan | Information Technology | Neurology | Nuclear Medicine | South Africa Health | SPECT | Statistics | Study | Urology & Nephrology